FDA's Vaccines and Related Biological Products Advisory Committee unanimously recommended Moderna's mRNA flu vaccine for adults 50 and older.
Moderna's mRNA-based flu shot overcomes controversy after the FDA briefly refused to review it weeks earlier.
The vote comes as a rebuke of the FDA's former leadership, which had questioned the vaccine's trial design.
Sources:
FDA committee recommends a new mRNA flu vaccine - NPR
Moderna Announces FDA Advisory Committee Votes Unanimously ...
Moderna’s mRNA flu shot wins unanimous support at FDA adcomm in rebuke of former leadership
FDA committee unanimously recommends first mRNA flu vaccine
FDA advisory panel votes 9-0 in favor of Moderna's mRNA flu vaccine
Moderna mRNA Flu Vaccine Wins FDA Advisory Committee Backing
FDA does U-turn, will review Moderna's mRNA flu shot after shocking rejection
Moderna's flu candidate sails through FDA adcomm - Fierce Biotech
FDA panel considers a first-of-its-kind flu vaccine using mRNA ...
F.D.A. Reverses Decision and Agrees to Review Moderna's Flu Vaccine
Moderna flu vaccine wins unanimous support from FDA panel
FDA refuses to review Moderna's mRNA flu vaccine - BioPharma Dive